The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current revenue (TTM ) is NZ$56.30 Billion. In 2023 the company made a revenue of NZ$44.57 Billion an increase over the revenue in the year 2022 that were of NZ$41.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.